Day: May 27, 2015

ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV

LONDON, United-Kingdom, May 26, 2015/ — ViiV Healthcare (, Aurobindo Pharma (, and the Clinton Health Access Initiative, Inc. (CHAI) ( announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for Tentative Approval,… Read More ›